Literature DB >> 12842436

Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo.

Siobhan M Cashman1, David J Morris, Rajendra Kumar-Singh.   

Abstract

The human immunodeficiency virus type-1 Tat protein is known to exit virally infected cells and enter the nucleus of adjacent uninfected cells. This property has been mapped to an 11-amino-acid protein transduction domain (PTD). When the PTD of Tat is fused to heterologous proteins and added exogenously to cells, the fusion peptide is able to demonstrate protein transduction across plasma membranes. Recent reports indicate that endogenously expressed Tat fusion peptides can demonstrate intercellular transport and improve biodistribution of therapeutic protein in the context of adenovirus vectors. Intercellular transport and protein transduction have not been observed in some studies and in the former have been attributed to an artifact of fixation. We have attempted to resolve these studies using an approach that unambiguously distinguishes cells that express Tat fusion protein from those that receive it from their environment. We find no evidence of intercellular transport in the context of an adenovirus vector in cell culture or in vivo. Instead, we find that Tat fusion peptides are down regulated in terms of expression not only in the context of adenovirus vectors, but also when expressed from transfected plasmid DNA. However, when Tat fusion peptides are released from cells by degradation of the plasma membrane, the fusion peptides demonstrate protein transduction without the need for cell fixation, indicating a unidirectional transport of Tat fusion proteins across the plasma membrane. Our data are consistent with previously reported studies and help to explain the apparently different results obtained from several different laboratories.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842436     DOI: 10.1016/s1525-0016(03)00131-x

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  11 in total

1.  Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity.

Authors:  Ying Shen; William Yu; John G Hay; Harald Sauthoff
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

Review 2.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

3.  Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea.

Authors:  Leslie N Johnson; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Mol Ther       Date:  2007-10-09       Impact factor: 11.454

4.  G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.

Authors:  Derek Leaderer; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Exp Eye Res       Date:  2016-02-27       Impact factor: 3.467

Review 5.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

6.  POD nanoparticles expressing GDNF provide structural and functional rescue of light-induced retinal degeneration in an adult mouse.

Authors:  Sarah P Read; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Mol Ther       Date:  2010-08-10       Impact factor: 11.454

Review 7.  Barriers for retinal gene therapy: separating fact from fiction.

Authors:  Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2008-06-18       Impact factor: 1.886

Review 8.  Biological applications of protein transduction technology.

Authors:  Panagiotis S Kabouridis
Journal:  Trends Biotechnol       Date:  2003-11       Impact factor: 19.536

9.  Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin.

Authors:  Leslie N Johnson; Siobhan M Cashman; Sarah Parker Read; Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2009-09-03       Impact factor: 1.886

Review 10.  Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?

Authors:  Fons A J van de Loo; Ruben L Smeets; Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2004-07-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.